Healthcare provider profile · identity verified

Daniel Albert Litovsky, MD

Allopathic & Osteopathic Physicians|Internal Medicine · LANGHORNE, PA · NPI 1275583403

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Daniel Albert Litovsky, MD received $70.44 in general payments during 2025 across 4 reported records.

Inari Medical, Inc. accounted for 29.5% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 6 associated products.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 164 claims for Ozempic by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 100 claims for Eliquis by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 56 claims for Paxlovid by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$70.44

4 reported records · 4 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Inari Medical, Inc.	Unresolved — no canonical attribution shown	$20.77	29.5%	1	2025
Sumitomo Pharma America, Inc.	Unresolved — no canonical attribution shown	$17.97	25.5%	1	2025
PFIZER INC.	Unresolved — no canonical attribution shown	$17.14	24.3%	1	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$14.56	20.7%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$70.44	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit	Device	Inari Medical, Inc.	$20.77	1	2025
Source payment records 2025-02-13 · Inari Medical, Inc. · $20.77 · Open Payments source
FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s	Device	Inari Medical, Inc.	$20.77	1	2025
Source payment records 2025-02-13 · Inari Medical, Inc. · $20.77 · Open Payments source
GEMTESA Normalized: gemtesa	Drug	Sumitomo Pharma America, Inc.	$17.97	1	2025
Source payment records 2025-02-04 · Sumitomo Pharma America, Inc. · $17.97 · Open Payments source
NURTEC ODT Normalized: nurtec odt	Drug	PFIZER INC.	$17.14	1	2025
Source payment records 2025-03-06 · PFIZER INC. · $17.14 · Open Payments source
ZAVZPRET Normalized: zavzpret	Drug	PFIZER INC.	$17.14	1	2025
Source payment records 2025-03-06 · PFIZER INC. · $17.14 · Open Payments source
Wegovy Normalized: wegovy	Drug	Novo Nordisk Inc	$14.56	1	2025
Source payment records 2025-06-12 · Novo Nordisk Inc · $14.56 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	164	25
PFIZER INC. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063	Eliquis · 2024 Exact normalized brand match · 1 Part D row	100	31
PFIZER INC. Exact reporting entity; no affiliate inference	2025	PAXLOVID open payments reported associated product	CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432	Paxlovid · 2024 Exact normalized brand match · 1 Part D row	56	56

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	710	228
Atorvastatin Calcium	Atorvastatin Calcium	705	217
Losartan Potassium	Losartan Potassium	617	193
Levothyroxine Sodium	Levothyroxine Sodium	577	179
Amlodipine Besylate	Amlodipine Besylate	505	169
Pantoprazole Sodium	Pantoprazole Sodium	376	128
Alprazolam	Alprazolam	357	94
Metoprolol Succinate	Metoprolol Succinate	341	111
Metformin Hcl	Metformin Hcl	283	77
Omeprazole	Omeprazole	274	89
Gabapentin	Gabapentin	273	83
Lisinopril	Lisinopril	239	76
Hydrochlorothiazide	Hydrochlorothiazide	215	69
Simvastatin	Simvastatin	203	61
Ezetimibe	Ezetimibe	202	66
Sertraline Hcl	Sertraline Hcl	196	56
Furosemide	Furosemide	182	63
Ozempic	Semaglutide	164	25
Fluticasone Propionate	Fluticasone Propionate	155	72
Tamsulosin Hcl	Tamsulosin Hcl	146	46
Valsartan	Valsartan	146	47
Synthroid	Levothyroxine Sodium	145	36
Zolpidem Tartrate	Zolpidem Tartrate	145	37
Montelukast Sodium	Montelukast Sodium	143	44
Escitalopram Oxalate	Escitalopram Oxalate	142	43
Prednisone	Prednisone	139	98
Allopurinol	Allopurinol	138	36
Hydralazine Hcl	Hydralazine Hcl	135	47
Trazodone Hcl	Trazodone Hcl	135	44
Metformin Hcl Er	Metformin Hcl	133	47
Metoprolol Tartrate	Metoprolol Tartrate	133	41
Famotidine	Famotidine	131	45
Duloxetine Hcl	Duloxetine Hcl	130	39
Clonazepam	Clonazepam	124	29
Methylprednisolone	Methylprednisolone	123	106
Tramadol Hcl	Tramadol Hcl	119	37
Carvedilol	Carvedilol	113	34
Pravastatin Sodium	Pravastatin Sodium	112	36
Azelastine Hcl	Azelastine Hcl	111	49
Clopidogrel	Clopidogrel Bisulfate	110	40
Bupropion Xl	Bupropion Hcl	108	29
Fluoxetine Hcl	Fluoxetine Hcl	107	28
Eliquis	Apixaban	100	31
Atenolol	Atenolol	99	26
Lorazepam	Lorazepam	99	39
Azithromycin	Azithromycin	98	85
Irbesartan	Irbesartan	98	30
Meloxicam	Meloxicam	98	33
Bumetanide	Bumetanide	95	35
Jardiance	Empagliflozin	90	30
Albuterol Sulfate Hfa	Albuterol Sulfate	78	46
Finasteride	Finasteride	77	26
Potassium Chloride	Potassium Chloride	73	23
Donepezil Hcl	Donepezil Hcl	69	19
Mounjaro	Tirzepatide	68	suppressed
Repaglinide	Repaglinide	68	21
Venlafaxine Hcl Er	Venlafaxine Hcl	68	16
Celecoxib	Celecoxib	67	19
Januvia	Sitagliptin Phosphate	66	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	61	16
Spironolactone	Spironolactone	60	21
Doxycycline Hyclate	Doxycycline Hyclate	58	47
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	58	48
Tizanidine Hcl	Tizanidine Hcl	58	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	57	47
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	16
Paxlovid	Nirmatrelvir/Ritonavir	56	56
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	50	40
Farxiga	Dapagliflozin Propanediol	50	15
Mirtazapine	Mirtazapine	50	14
Ibuprofen	Ibuprofen	48	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	47	12
Ipratropium Bromide	Ipratropium Bromide	44	14
Meclizine Hcl	Meclizine Hcl	44	19
Citalopram Hbr	Citalopram Hydrobromide	43	13
Diazepam	Diazepam	43	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	13
Cefuroxime	Cefuroxime Axetil	41	36
Cephalexin	Cephalexin	41	35
Valacyclovir	Valacyclovir Hcl	41	17
Glipizide Er	Glipizide	39	15
Glimepiride	Glimepiride	38	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	11
Xarelto	Rivaroxaban	38	suppressed
Pregabalin	Pregabalin	37	suppressed
Tradjenta	Linagliptin	37	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	36	suppressed
Buspirone Hcl	Buspirone Hcl	33	14
Dicyclomine Hcl	Dicyclomine Hcl	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	24
Ramipril	Ramipril	32	11
Alendronate Sodium	Alendronate Sodium	31	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	31	suppressed
Propranolol Hcl Er	Propranolol Hcl	30	suppressed
Raloxifene Hcl	Raloxifene Hcl	30	suppressed
Temazepam	Temazepam	30	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	28	suppressed
Nystatin	Nystatin	28	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Amoxicillin	Amoxicillin	26	22
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	18
Icosapent Ethyl	Icosapent Ethyl	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	12
Naproxen	Naproxen	25	suppressed
Ondansetron Odt	Ondansetron	25	17
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	24	suppressed
Primidone	Primidone	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Mupirocin	Mupirocin	23	17
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Constulose	Lactulose	22	suppressed
Glipizide	Glipizide	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Sodium Chloride	0.9 % Sodium Chloride	16	suppressed
Myrbetriq	Mirabegron	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Colchicine	Colchicine	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Methylphenidate Er	Methylphenidate Hcl	14	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	14	suppressed
Alogliptin	Alogliptin Benzoate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Triazolam	Triazolam	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Carvedilol Er	Carvedilol Phosphate	12	suppressed
Nadolol	Nadolol	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Torsemide	Torsemide	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Xanax	Alprazolam	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Baclofen	Baclofen	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Estradiol	Estradiol	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Nystop	Nystatin	11	suppressed
Prolia	Denosumab	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$70.44 · 4 records	Inari Medical, Inc.	CT THROMBECTOMY SYSTEM KIT, FLOWTRIEVER CATHETER, S, GEMTESA, NURTEC ODT, Wegovy, ZAVZPRET	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error